Unlocking Precision Medicine
New medicines in the pipeline can extend lives, save money, and even help prevent disease before symptoms appear – if we don’t discourage their innovators and investors by trying to lower drug prices artificially. Unlocking Precision Medicine explores the environment necessary for creation of these health care game-changers, and explains how the marketplace can effectively make them more affordable to all without killing the golden goose.  
1124243949
Unlocking Precision Medicine
New medicines in the pipeline can extend lives, save money, and even help prevent disease before symptoms appear – if we don’t discourage their innovators and investors by trying to lower drug prices artificially. Unlocking Precision Medicine explores the environment necessary for creation of these health care game-changers, and explains how the marketplace can effectively make them more affordable to all without killing the golden goose.  
5.99 In Stock
Unlocking Precision Medicine

Unlocking Precision Medicine

Unlocking Precision Medicine

Unlocking Precision Medicine

Paperback

$5.99 
  • SHIP THIS ITEM
    Ships in 6-10 days
  • PICK UP IN STORE

    Your local store may have stock of this item.

Related collections and offers


Overview

New medicines in the pipeline can extend lives, save money, and even help prevent disease before symptoms appear – if we don’t discourage their innovators and investors by trying to lower drug prices artificially. Unlocking Precision Medicine explores the environment necessary for creation of these health care game-changers, and explains how the marketplace can effectively make them more affordable to all without killing the golden goose.  

Product Details

ISBN-13: 9781594039171
Publisher: Encounter Books
Publication date: 11/01/2016
Series: Encounter Intelligence
Pages: 48
Product dimensions: 5.10(w) x 7.30(h) x 0.50(d)

About the Author

Paul Howard is a senior fellow at the Manhattan Institute and director of health policy. Howard was part of the health care policy advisory group for Mitt Romney’s 2012 presidential campaign, has testified twice before Congress, and serves on a panel of judges for Celgene’s Innovation Impact Awards. He is a contributor to The Apothecary, the Forbes blog on health care policy and entitlement reform, and a regular columnist for The Morning Consult.
 
Peter Huber is a senior fellow at the Manhattan Institute, where he writes on drug development, energy, technology, and the law. His most recent full length book is The Cure in the Code: How 20th Century Law Is Undermining 21st Century Medicine. Before joining MI, Huber was an associate professor at MIT. He clerked on the D.C. Circuit Court of Appeals for Ruth Bader Ginsburg and on the U.S. Supreme Court for Sandra Day O’Connor.
From the B&N Reads Blog

Customer Reviews